• Study on the Safety and Effects of NVG-2089 for Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Bulgaria France Italy Poland Spain

  • Study on the Effectiveness and Safety of JNJ-95475939 and Dupilumab for Treating Moderate to Severe Atopic Dermatitis in Adults

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany Poland Spain

  • Study on Personalized Treatment Using Dapagliflozin, Dulaglutide, and Metformin for Patients with Uncontrolled Type 2 Diabetes

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Study on the Effectiveness of Survodutide for Weight Loss in Patients with Type 2 Diabetes and Obesity

    Not recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    Belgium Czechia Denmark Finland Germany Greece +5

  • Study of Teclistamab for Patients with Previously Treated AL Amyloidosis

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Greece Italy The Netherlands

  • Study on the Effectiveness of Survodutide for Weight Loss in Adults with Obesity Without Diabetes

    Not recruiting

    3 1
    Investigated drugs:
    Belgium Finland Germany The Netherlands Poland Sweden

  • Study on the Effects of ION363 for Patients with Amyotrophic Lateral Sclerosis with Fused in Sarcoma Mutations

    Not recruiting

    4 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Germany Ireland Italy The Netherlands Poland +2

  • Title: Study of Sibeprenlimab Treatment for Adults with Sjögren’s Disease Using Subcutaneous Injections

    Not recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria Germany Greece Poland Romania Spain

  • Study of PRT3789 and Pembrolizumab for Patients with Advanced Solid Tumors, Esophageal Cancer, or NSCLC with SMARCA4 Mutation

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Spain

  • Study on the Effectiveness and Safety of Lunsekimig (SAR443765) for Adults with Moderate to Severe Atopic Dermatitis

    Not recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    Czechia Poland

powered by